IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners LLC

Q2 2026 Holdings

Filed 2026-08-14 | 7 holdings | $519.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N V(PHVS)COMN69605108$160.6M4,643,43030.9%
Parabilis Medicines Inc(PBLS)COM698955101$144.1M5,266,69727.8%
Alumis Inc(ALMS)COM022307102$127.4M4,528,40824.5%
Achieve Life Science Inc(ACHV)COM004468500$38.6M5,914,7207.4%
ALX Oncology Hldgs Inc(ALXO)COM00166B105$26.7M12,884,6385.1%
Harmony Biosciences Hldgs in(HRMY)COM413197104$17.2M472,1943.3%
Lyell Immunopharma Inc(LYEL)COM NEW55083R203$4.7M337,6970.9%